Perbak Capital Partners LLP Buys Shares of 4,911 Danaher Co. (NYSE:DHR)

Perbak Capital Partners LLP bought a new stake in Danaher Co. (NYSE:DHR) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,911 shares of the conglomerate’s stock, valued at approximately $1,127,000.

A number of other institutional investors also recently bought and sold shares of the company. Gilbert & Cook Inc. grew its stake in shares of Danaher by 2.5% during the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock worth $401,000 after acquiring an additional 42 shares in the last quarter. Grimes & Company Inc. grew its stake in shares of Danaher by 0.6% during the 4th quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after acquiring an additional 43 shares in the last quarter. Dakota Community Bank & Trust NA grew its stake in shares of Danaher by 16.4% during the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock worth $73,000 after acquiring an additional 45 shares in the last quarter. Howard Capital Management Group LLC grew its stake in shares of Danaher by 4.1% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 48 shares in the last quarter. Finally, Spinnaker Trust grew its stake in shares of Danaher by 1.2% during the 4th quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock worth $988,000 after acquiring an additional 50 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 11.10% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on DHR shares. Jefferies Financial Group decreased their price target on shares of Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research note on Tuesday, April 22nd. UBS Group cut their price objective on Danaher from $275.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. The Goldman Sachs Group cut their price objective on Danaher from $260.00 to $240.00 and set a “neutral” rating for the company in a report on Wednesday, April 23rd. Stifel Nicolaus raised Danaher from a “hold” rating to a “buy” rating and set a $260.00 price objective for the company in a report on Friday, March 14th. Finally, Citigroup reissued a “buy” rating on shares of Danaher in a report on Monday, April 7th. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $264.40.

Danaher Trading Down 0.6 %

DHR opened at $196.01 on Tuesday. Danaher Co. has a twelve month low of $171.00 and a twelve month high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company has a fifty day moving average of $200.69 and a 200-day moving average of $223.46. The stock has a market cap of $140.28 billion, a PE ratio of 37.12, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. On average, sell-side analysts predict that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 25th. Stockholders of record on Friday, March 28th were issued a $0.32 dividend. The ex-dividend date was Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. Danaher’s dividend payout ratio is currently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.